Bookmark

Add to MyYahoo RSS

Genentech News

News on Genentech (Ticker: RHHBY) continually updated from thousands of sources around the net.

Yesterday | Hispanic Business

Donaco International Limited (ASX:DNA) On-Market Buy-Back and Appendix 3C

The buy-back is being undertaken as part of the Company's ongoing capital management program.

Comment?

Related Topix: Startups

Monday | HON

Asthma Drug May Help Those With Chronic Hives

A drug already used to treat moderate-to-severe allergic asthma appears to offer relief to people with chronic hives who haven't been helped by standard medications, new research suggests.

Comment?

Related Topix: Hives, Medicine, Food and Drug Administration, Startups, Dermatology

Sat Jul 19, 2014

WJRT

Genentech Alzheimer's drug misses goals in studies

An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.

Comment?

Related Topix: Startups, Alzheimer's, Health

Wed Jul 16, 2014

Hispanic Business

Recent Findings from Genentech, Inc. Provides New Insights into...

Small-scale studies performed at the 2 L scale consistently showed an increase in acidic species when compared with the material made at larger scale."

Comment?

Related Topix: Startups

KWQC-TV Davenport

Genentech Alzheimer's drug misses goals in studies

An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.

Comment?

Related Topix: Startups, Alzheimer's, Health

Mon Jul 14, 2014

Business Journal

Skin cancer drug combo with Genentech sends Exelixis stock soaring

Exelixis, led by President and CEO Michael Morrissey, expects partner Genentech to seek FDA approval of a combination of Zelboraf and cobimetinib later this year.

Comment?

Related Topix: Startups, Exelixis, Skin Cancer, Medicine, Health, Healthcare Law, Law, Food and Drug Administration

Wed Jul 09, 2014

Hispanic Business

Genentech Announces Definitive Agreement to Acquire Seragon Pharmaceuticals

"This year, breast cancer will claim the lives of nearly 40,000 women in . "We believe these investigational oral SERDs could one day redefine the standard of care for hormone receptor-positive breast cancer."

Comment?

Related Topix: Startups, Health, Breast Cancer

Business Journal

Energy-saving FlexLab at Lawrence Berkeley opens Thursday

The energy-saving buildings of tomorrow are spinning out today, thanks to a Lawrence Berkeley National Laboratory center that officially opens Thursday.

Comment?

Related Topix: Startups

Canada NewsWire

Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors

"It is a privilege to join this talented Board of Directors, and I am excited about the opportunity to work with the Board and management to make Coherus the leader in the emerging business of biosimilars," Dr. Lawlis stated.

Comment?

Related Topix: Biotech, Science / Technology, Akzo Nobel NV, Manufacturing, Chemicals, Startups

NatureNews

Seven days: 4-10 July 2014

Novartis charged Prosecutors in Tokyo announced last week that they would pursue charges against a Japanese subsidiary of drug giant Novartis and one of the company's former employees, Nobuo Shirahashi.

Comment?

Related Topix: Medicine, Diovan, Valsartan (generic), Biotech, Startups, Science / Technology, San Mateo County, CA, South San Francisco, CA, San Francisco County, CA, San Francisco, CA

Tue Jul 08, 2014

Hispanic Business

Dalradian Announces Increase to Previously Announced Bought Deal Unit Financing

The Company has granted the Underwriters an option to purchase up to an additional 15% of the Offering , exercisable for a period of up to 30 days after the closing date , if the Over-Allotment Option is fully exercised, the total gross proceeds from the Offering will be .

Comment?

Related Topix: Startups

Mon Jul 07, 2014

Fox News

Experimental asthma drug hits a new target

An experimental drug that could help people with asthma or allergies works in a new way, by blocking the production of an inflammatory protein, according to a new study.

Comment?

Related Topix: Medicine, Asthma, Health, Allergy and Immunology, Startups

Thu Jul 03, 2014

Business Journal

Meet 'et al': The mystery man behind some of the world's most powerful drugs

The patents behind humanized monoclonal antibodies - the biotechnology behind such life-changing medicines as Genentech Inc.'s Avastin and Herceptin and Biogen Idec Inc.'s Tysabri - generally are known as the "Queen patents" for inventor Cary Queen .

Comment?

Related Topix: Startups, Inventions, Science / Technology, San Mateo County, CA, South San Francisco, CA, PDL BioPharma

Wall Street Journal

The Daily Startup: Large Russian Venture Fund Looks Elsewhere for Investments

Runa Capital , a venture firm founded by entrepreneurs with strong Moscow ties, is raising a second venture fund that will haul in between $200 million and $300 million, Yuliya Chernova reports in VentureWire.

Comment?

Related Topix: Startups, Five Prime Therapeutics, Venture Capital, Emerging Technology, Biotech, Science / Technology, Kleiner Perkins Caufield and Byers, Financial Services, Kleiner Perkins Caufield & Byers, Investment Services

Wed Jul 02, 2014

Alabama Live

Mega mergers, Malaysian Air, gas, Google, fast food, mobile advertising, PR secrets, LeBron, Star Trek and Bitcoin in today's business news

Mega mergers, Malaysian Air, gas, Google, fast food, mobile advertising, PR secrets, LeBron, Star Trek and Bitcoin in today's business news From Google to gas prices to fast food to mega deals and mobile advertising here is a plethora of national and international business headlines this Wednesday, July 2. Switzerland's Roche Holding AG says its ... (more)

Comment?

Related Topix: Life, Food, Fast Food, Public Relations, Mobile Marketing, Startups

Live Science

Experimental Asthma Drug Hits a New Target

An experimental drug that could help people with asthma or allergies works in a new way, by blocking the production of an inflammatory protein, according to a new study.

Comment?

Related Topix: Medicine, Asthma, Health, Allergy and Immunology, Startups

WAFB-TV Baton Rouge

Roche buying Seragon in US for up to $1.7 billion

A hurricane watch was issued for part of North Carolina's coast early Wednesday as Tropical Storm Arthur moved northward, threatening Fourth of July plans along the East Coast.

Comment?

Related Topix: Hurricane, Natural Disasters, Drama Movies, Comedy Movies, Bob & Carol & Ted & Alice, Startups

The Washington Post

Roche to Buy Seragon for Up to $1.7 Billion for Cancer Drugs

Roche Holding AG, the world's biggest maker of cancer drugs, agreed to buy Seragon Pharmaceuticals Inc. for as much as $1.7 billion to gain a new generation of experimental treatments for breast tumors.

Comment?

Related Topix: Startups, Health, Breast Cancer, Business News

Wall Street Journal

Roche Buys U.S. Cancer Drug Maker

Roche Holding AG said Wednesday it would pay $725 million in cash to acquire a San Diego-based developer of breast cancer treatments, adding to the oncology giant's pipeline of potential products.

Comment?

Related Topix: Medicine, Cancer, Health, Startups, Pegasys, Biotech, Roche Holding, Roche Group, 454, Healthcare Industry, Opinion

Tue Jul 01, 2014

Business Wire

Genentech Announces Definitive Agreement to Acquire Seragon Pharmaceuticals

With this acquisition, Genentech obtains rights to Seragon's entire portfolio of investigational next-generation oral selective estrogen receptor degraders for the potential treatment of hormone receptor-positive breast cancer.

Comment?

Related Topix: Startups, Biotech, Medicine, Roche Group, Healthcare Industry, Health, Breast Cancer

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••